Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,902,951
-$575,296 QoQ
Shares Held
177,846
-20.8% QoQ
Ownership
0.897%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 131 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. KROS ranks #228 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in KROS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,902,951 | 177,846 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,478,247 | 224,479 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,022,925 | 590,517 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $20,969,140 | 1,325,483 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $11,795,525 | 883,560 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,546,775 | 740,606 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $8,478,294 | 535,584 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $20,653,408 | 355,664 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $23,830,127 | 521,447 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $17,103,961 | 258,368 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,154,735 | 205,099 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,189,880 | 100,059 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $2,969,582 | 73,907 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $2,658,501 | 62,260 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $7,002,371 | 145,822 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $6,634,813 | 176,364 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $4,085,122 | 147,851 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $6,951,449 | 127,831 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,980,125 | 119,298 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $2,053,520 | 51,909 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $954,300 | 22,470 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $391,581 | 6,362 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,740,964 | 123,915 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $683,383 | 17,718 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||